Myocardial Ischemia/Reperfusion Injury and Infarct Size in Vivo
暂无分享,去创建一个
L. V. von Segesser | P. Nicod | C. Bonny | G. Vassalli | G. Milano | S. Morel | M. Samaja | L. Segesser
[1] J. Comella,et al. Switch from Caspase-dependent to Caspase-independent Death during Heart Development , 2006, Journal of Biological Chemistry.
[2] L. Kappenberger,et al. Brief reoxygenation episodes during chronic hypoxia enhance posthypoxic recovery of LV function , 2006, Basic Research in Cardiology.
[3] Yow-Ming C Wang,et al. c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo , 2005, Circulation research.
[4] T. Hewett,et al. Genetic Inhibition or Activation of JNK1/2 Protects the Myocardium from Ischemia-Reperfusion-induced Cell Death in Vivo* , 2005, Journal of Biological Chemistry.
[5] K. Webster,et al. Mitochondrial signals initiate the activation of c‐Jun N‐terminal kinase (JNK) by hypoxia‐reoxygenation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] C. Niesler,et al. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes , 2004, Basic Research in Cardiology.
[7] F. de Ribaupierre,et al. A Peptide Inhibitor of C-jun N-terminal Kinase Protects against Both Aminoglycoside and Acoustic Trauma-induced Auditory Hair Cell Death and Hearing Loss , 2022 .
[8] A. Vercelli,et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia , 2003, Nature Medicine.
[9] D. Sawyer,et al. H(2)O(2) regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. , 2003, Journal of molecular and cellular cardiology.
[10] R. Lauro,et al. Characterization of apoptosis signal transduction pathways in HL‐5 cardiomyocytes exposed to ischemia/reperfusion oxidative stress model , 2003, Journal of cellular physiology.
[11] D. Sawyer,et al. &bgr;-Adrenergic Receptor–Stimulated Apoptosis in Cardiac Myocytes Is Mediated by Reactive Oxygen Species/c-Jun NH2-Terminal Kinase–Dependent Activation of the Mitochondrial Pathway , 2003, Circulation research.
[12] M. Bogoyevitch,et al. Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity* , 2002, The Journal of Biological Chemistry.
[13] P. Kang,et al. Direct Activation of Mitochondrial Apoptosis Machinery by c-Jun N-terminal Kinase in Adult Cardiac Myocytes* , 2002, The Journal of Biological Chemistry.
[14] K. Webster,et al. Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. , 2002, The Biochemical journal.
[15] R. Fryer,et al. Stress-activated protein kinase phosphorylation during cardioprotection in the ischemic myocardium. , 2001, American journal of physiology. Heart and circulatory physiology.
[16] B. Monia,et al. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. , 2001, Molecular pharmacology.
[17] K. Webster,et al. Cytoprotection by Jun Kinase During Nitric Oxide–Induced Cardiac Myocyte Apoptosis , 2001, Circulation research.
[18] P. Pratt,et al. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. , 2001, The Journal of pharmacology and experimental therapeutics.
[19] R. Weiss,et al. Antioxidant therapy attenuates JNK activation and apoptosis in the remote noninfarcted myocardium after large myocardial infarction. , 2001, Biochemical and biophysical research communications.
[20] D. Schorderet,et al. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. , 2001, Diabetes.
[21] D. Schorderet,et al. Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of β-Cell Death , 2001 .
[22] T. Yue,et al. Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. , 2000, Circulation research.
[23] Jiahuai Han,et al. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. , 1999, American journal of physiology. Heart and circulatory physiology.
[24] T. Tan,et al. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin , 1998, Oncogene.
[25] A. Clerk,et al. The p38‐MAPK inhibitor, SB203580, inhibits cardiac stress‐activated protein kinases/c‐Jun N‐terminal kinases (SAPKs/JNKs) , 1998, FEBS letters.
[26] Shokei Kim,et al. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. , 1998, Cardiovascular research.
[27] Y. Yazaki,et al. Hypoxia and hypoxia/reoxygenation activate p65PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes. , 1997, Biochemical and biophysical research communications.
[28] Tsonwin Hai,et al. Tissue-specific Pattern of Stress Kinase Activation in Ischemic/Reperfused Heart and Kidney* , 1997, The Journal of Biological Chemistry.
[29] K. Yoshioka,et al. A Novel Mechanism of JNK1 Activation , 1997, The Journal of Biological Chemistry.
[30] K. Webster,et al. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. , 1997, Circulation research.
[31] D. Buxton,et al. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. , 1996, Biochemical and biophysical research communications.
[32] M. Cohen,et al. Preconditioning During Ischemia: Basic Mechanisms and Potential Clinical Applications , 1995 .